Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$527.67 +1.48 (+0.28%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Cash & Current Investments (2009 - 2026)

Updated

Vertex Pharmaceuticals (VRTX) posted Cash & Current Investments of $7.85 billion for Q2 2026, up 23.0% from $6.38 billion a year earlier and up 8.4% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Vertex Pharmaceuticals' Cash & Current Investments came in at $6.61 billion, up 8.0% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
  • In prior years, Vertex Pharmaceuticals' Cash & Current Investments was $6.12 billion in FY2024 (-45.5%), $11.22 billion in FY2023 (+4.1%), $10.78 billion in FY2022 (+43.2%) and $7.52 billion in FY2021 (+13.0%).
  • The Q2 2026 figure stands as the highest quarterly Cash & Current Investments since Q1 2024.
  • On a year-over-year basis, Cash & Current Investments has increased in each of the last three quarters, with an average decline of 9.4% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2022, with growth of 43.2%; the weakest was Q2 2024, with a decline of 48.4%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $7.25 billion (Q1 2026), $6.61 billion (Q4 2025) and $6.29 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 20.76 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 6.57 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 7.14 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 9.92 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 4.97 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 3.18 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 11.70 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 7.85 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 11.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.85 Bn
Mar 31, 2026 7.25 Bn
Dec 31, 2025 6.61 Bn
Sep 30, 2025 6.29 Bn
Jun 30, 2025 6.38 Bn
Mar 31, 2025 6.20 Bn
Dec 31, 2024 6.12 Bn
Sep 30, 2024 6.52 Bn
Jun 30, 2024 5.80 Bn
Mar 31, 2024 10.17 Bn
Dec 31, 2023 11.22 Bn
Sep 30, 2023 11.93 Bn
Jun 30, 2023 11.24 Bn
Mar 31, 2023 10.41 Bn
Dec 31, 2022 10.78 Bn
Sep 30, 2022 9.77 Bn
Jun 30, 2022 9.25 Bn
Mar 31, 2022 8.24 Bn
Dec 31, 2021 7.52 Bn
Sep 30, 2021 6.96 Bn
API Access

Vertex Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VRTX&period=max&api_key=YOUR_API_KEY